Evaluation of the Rosa Chatbot Providing Genetic Information to Patients at Risk of Hereditary Breast and Ovarian Cancer: Qualitative Interview Study

Journals

1. Nääs C, von Salomé J, Rosén A. Patients’ perceptions and practices of informing relatives: a qualitative study within a randomised trial on healthcare-assisted risk disclosure. European Journal of Human Genetics 2024;32(4):448 View
2. Laymouna M, Ma Y, Lessard D, Schuster T, Engler K, Lebouché B. Roles, Users, Benefits, and Limitations of Chatbots in Health Care: Rapid Review. Journal of Medical Internet Research 2024;26:e56930 View
3. Ozcelik F, Dundar M, Yildirim A, Henehan G, Vicente O, Sánchez-Alcázar J, Gokce N, Yildirim D, Bingol N, Karanfilska D, Bertelli M, Pojskic L, Ercan M, Kellermayer M, Sahin I, Greiner-Tollersrud O, Tan B, Martin D, Marks R, Prakash S, Yakubi M, Beccari T, Lal R, Temel S, Fournier I, Ergoren M, Mechler A, Salzet M, Maffia M, Danalev D, Sun Q, Nei L, Matulis D, Tapaloaga D, Janecke A, Bown J, Cruz K, Radecka I, Ozturk C, Nalbantoglu O, Sag S, Ko K, Arngrimsson R, Belo I, Akalin H, Dundar M. The impact and future of artificial intelligence in medical genetics and molecular medicine: an ongoing revolution. Functional & Integrative Genomics 2024;24(4) View
4. Kaphingst K, Kohlmann W, Lorenz Chambers R, Bather J, Goodman M, Bradshaw R, Chavez-Yenter D, Colonna S, Espinel W, Everett J, Flynn M, Gammon A, Harris A, Hess R, Kaiser-Jackson L, Lee S, Monahan R, Schiffman J, Volkmar M, Wetter D, Zhong L, Mann D, Ginsburg O, Sigireddi M, Kawamoto K, Del Fiol G, Buys S. Uptake of Cancer Genetic Services for Chatbot vs Standard-of-Care Delivery Models. JAMA Network Open 2024;7(9):e2432143 View
5. Tagliaferri L, Fionda B, Casà C, Cornacchione P, Scalise S, Chiesa S, Marconi E, Dinapoli L, Di Capua B, Chieffo D, Marazzi F, Frascino V, Colloca G, Valentini V, Miccichè F, Gambacorta M. Allies not enemies—creating a more empathetic and uplifting patient experience through technology and art. Strahlentherapie und Onkologie 2025;201(3):316 View
6. Russell C, Daley A, Van Arnem D, Hila A, Johnson K, Davies J, Cytron H, Ready K, Armstrong C, Sylvester M, Caleshu C. Validation of a guidelines-based digital tool to assess the need for germline cancer genetic testing. Hereditary Cancer in Clinical Practice 2024;22(1) View
7. Sato A, Haneda E, Hiroshima Y, Narimatsu H. Preliminary Screening for Hereditary Breast and Ovarian Cancer Using an AI Chatbot as a Genetic Counselor: Clinical Study. Journal of Medical Internet Research 2024;26:e48914 View
8. Bather J, Goodman M, Harris A, Del Fiol G, Hess R, Wetter D, Chavez-Yenter D, Zhong L, Kaiser-Jackson L, Chambers R, Bradshaw R, Kohlmann W, Colonna S, Espinel W, Monahan R, Buys S, Ginsburg O, Kawamoto K, Kaphingst K. Social vulnerability and genetic service utilization among unaffected BRIDGE trial patients with inherited cancer susceptibility. BMC Cancer 2025;25(1) View
9. Jeon S, Lee S, Chung H, Yun J, Park E, So M, Huh J. Evaluating the Use of Generative Artificial Intelligence to Support Genetic Counseling for Rare Diseases. Diagnostics 2025;15(6):672 View
10. Nguyen O, Ahmad A, Wiegmann D. Correlates of Trust of Generative Artificial Intelligence Tools Among Patients and Caregivers: A Review of Empirical Research. Proceedings of the Human Factors and Ergonomics Society Annual Meeting 2025;69(1):1656 View
11. Li K, Wu S, Zhang Y, Zhu B, Qi Z, Hou S, Wang W. The Usability and Experience of Artificial Intelligence‐Based Conversational Agents in Health Education for Cancer Patients: A Scoping Review. Journal of Clinical Nursing 2025 View
12. Moultrie R, Andrews S, Williams K, Kutsa O, Hudnell T, Brailsford J, Aguilar S, Savage S, Biesecker B, Hunter J. Primary care patient and clinician attitudes about population genomic screening, informed decision‐making needs, and the potential for Chatbot technology. Journal of Genetic Counseling 2025;34(4) View
13. Wollney E, Sims S, Ricks-Santi L, Eddy E, Wiesman D, Fisher C. Implementing a chatbot to promote hereditary breast & ovarian cancer genetic screening in women’s health: identifying barriers and facilitators to screening adoption. BMC Public Health 2025;25(1) View
14. Morgan K, Goehringer J, Lindsey‐Mills Z, Brangan A, Kaur J, Walters N, Savage S, Sturm A, Campbell‐Salome G. User testing of a previsit chatbot developed for population genomic screening and counseling. Journal of Genetic Counseling 2025;34(4) View
15. Yi Y, Kaiser-Jackson L, Bather J, Goodman M, Chavez-Yenter D, Bradshaw R, Chambers R, Espinel W, Hess R, Mann D, Monahan R, Wetter D, Ginsburg O, Sigireddi M, Kawamoto K, Del Fiol G, Buys S, Kaphingst K. Bridging Technology and Pretest Genetic Services: Quantitative Study of Chatbot Interaction Patterns, User Characteristics, and Genetic Testing Decisions. Journal of Medical Internet Research 2025;27:e73391 View
16. Bosschaerts K, Kashefi A, De Marez L, Conradie P, Van Hoecke S, Ongenae F. Designing a just-in-time adaptive intervention with trigger detection and a generative chatbot: Smoking cessation use case. DIGITAL HEALTH 2025;11 View
17. Siglen E, Vetti H, Lyssand A, Dahl‐Michelsen T, Bjorvatn C. Patients' and healthcare professionals' experiences with implementing the Rosa chatbot in mainstream genetic testing for hereditary breast and ovarian cancer. Journal of Genetic Counseling 2025;34(5) View

Books/Policy Documents

1. Yuen J, De Guzman A, Courtney E, Ngeow J. International Encyclopedia of Public Health. View